GSH augmentation deserves investigation as a beneficial therapeutic approach for not only PD but also numerous other CNS disorders for which GSH deficiency and GSH-related enzyme deficits have been documented (multiple sclerosis, 25,26 autism, 2729 Alzheimers disease, 30,31 schizophrenia, 32,33 and bipolar disease 34 )
This knowledge serves as a basis for investigating whether pharmacological or other interventions can replicate the changes in gut-brain axis hormones observed after bariatric surgery, aiming to achieve metabolic benefits while minimizing surgical risks
Therefore, quercetins effects may alleviate clinical symptoms of orbital lesions in TAO patients
10.1016/s0092-8674(00)81554-8 Cell 13 BrennaA.OlejniczakI.ChavanR.RippergerJ
This syringe features an OSHA-compliant, safety-engineered sharp with a passive needle retraction system, eliminating the need for a separate capping step and enhancing user safety